The model provides a foundation for prospective evaluation of individualized exposure estimation using sparse VAMS sampling and demonstrates substantial interindividual exposure variability despite population-based dosing.
M. Scheetz, Justin Shiau, Victor Amajor et al.· International Journal of Ant...· 0 citations
ABSTRACT Cefepime is used in critically ill pneumonia patients, but dosing in renal replacement therapy (RRT) is complicated by altered renal function, extracorporeal removal, and variability in pulmonary epithelial lining fluid (ELF) exposure. We sought to develop an integrated model linking systemic, extracorporeal,...
A. Valadez, Emma Harlan, M. Scheetz et al.· Antimicrobial Agents and Che...· 0 citations
ABSTRACT The prevalence of non-susceptibility to ceftolozane-tazobactam (C/T) among Pseudomonas aeruginosa remains low, but novel mechanisms of C/T resistance are of concern. Herein, we describe a novel P. aeruginosa genotype associated with high-level C/T resistance (>256/4 µg/mL) in a single patient. Whole-genome seq...
Preeti Garai, Sophia H. Nozick, Caroline C. Jozefczyk et al.· Antimicrobial Agents and Che...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.